HomeMarkets Markets When Big Pharma Spends More on Stock Buybacks Than R&D By news January 10, 2023 0 115 FacebookTwitterPinterestWhatsApp The 14 largest publicly-traded pharmaceutical companies spent $747 billion on stock buybacks and dividends from 2012 through 2021 — substantially …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,670FansLike396,312FollowersFollow2,320SubscribersSubscribe Latest Articles Markets The end of the great China gold rush (updated) Charts PSW’s Weekly Webinar: FOMC Announcement News From moderate to manipulator: Behind the unmasking of Chief Justice John Roberts (updated) Health & Healthcare Doctors ‘fight like hell’ against a second Trump admin: ‘Elections do matter for your health’ Markets Leading AI Scientists Warn AI Could Escape Control at Any Moment Load more